Dasabuvir sodium; ombitasvir, paritaprevir, ritonavir - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for dasabuvir sodium; ombitasvir, paritaprevir, ritonavir and what is the scope of freedom to operate?
Dasabuvir sodium; ombitasvir, paritaprevir, ritonavir
is the generic ingredient in one branded drug marketed by Abbvie and is included in one NDA. There are seventeen patents protecting this compound. Additional information is available in the individual branded drug profile pages.Dasabuvir sodium; ombitasvir, paritaprevir, ritonavir has six hundred and twenty-one patent family members in fifty-four countries.
Summary for dasabuvir sodium; ombitasvir, paritaprevir, ritonavir
International Patents: | 621 |
US Patents: | 17 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | dasabuvir sodium; ombitasvir, paritaprevir, ritonavir at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for dasabuvir sodium; ombitasvir, paritaprevir, ritonavir
US Patents and Regulatory Information for dasabuvir sodium; ombitasvir, paritaprevir, ritonavir
Expired US Patents for dasabuvir sodium; ombitasvir, paritaprevir, ritonavir
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium; ombitasvir, paritaprevir, ritonavir | TABLET;ORAL | 206619-001 | Dec 19, 2014 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium; ombitasvir, paritaprevir, ritonavir | TABLET;ORAL | 206619-001 | Dec 19, 2014 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium; ombitasvir, paritaprevir, ritonavir | TABLET;ORAL | 206619-001 | Dec 19, 2014 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium; ombitasvir, paritaprevir, ritonavir | TABLET;ORAL | 206619-001 | Dec 19, 2014 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for dasabuvir sodium; ombitasvir, paritaprevir, ritonavir
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 103153988 | Anti-viral compounds | ⤷ Try a Trial |
New Zealand | 605440 | SOLID COMPOSITIONS COMPRISING AN HCV INHIBITOR | ⤷ Try a Trial |
Ecuador | SP13010937 | COMPUESTOS ANTIVIRALES | ⤷ Try a Trial |
Argentina | 086181 | METODO PARA PREPARAR INHIBIDORES MACROCICLICOS INHIBIDORES DE SERINA PROTEASAS DEL VIRUS DE LA HEPATITIS C | ⤷ Try a Trial |
Japan | 2020059696 | 抗ウィルス化合物 (ANTI-VIRAL COMPOUNDS) | ⤷ Try a Trial |
Cyprus | 1120377 | ⤷ Try a Trial | |
New Zealand | 606645 | Anti-viral compounds | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for dasabuvir sodium; ombitasvir, paritaprevir, ritonavir
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2340029 | PA2015011,C2340029 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: PARITAPREVIRAS; REGISTRATION NO/DATE: EU/1/14.982 20150115 |
2368890 | 300731 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: OMBITASVIR OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/14/982 20150119 |
2692346 | 17C1040 | France | ⤷ Try a Trial | PRODUCT NAME: PIBRENTASVIR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/17/1213 20170728 |
2692346 | PA2017033 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: PIBRENTASVIRAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/17/1213 20170726 |
2203431 | SPC/GB15/008 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: DASABUVIR, OR A SALT THEREOF; REGISTERED: UK EU/1/14/983 20150119 |
2368890 | C20150016 00154 | Estonia | ⤷ Try a Trial | PRODUCT NAME: OMBITASVIIR;REG NO/DATE: EU/1/14/982 19.01.2015 |
2692346 | SPC/GB17/056 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: PIBRENTASVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/17/1213 (NI) 20170728; UK PLGB 41042/0030 20170728; UK PLGB 41042/0043 20170728 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |